跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPRIL 5 TABLET 5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
DAPRIL 5 TABLET 5 MG
Approved
THERAPEUTIC
DAPRIL 5 TABLET 5 MG
MEDOCHEMIE LTD - CENTRAL FACTORY - CYPRUSMEDOCHEMIE LTD - FACTORY AZ (PRIMARY & SECONDARY PACKAGER) (CYPRUS)
🇸🇬 Health Sciences Authority
Approval Date
Jun 24, 2002
Approval ID
5605fc951277f8fc
Company
MEDOCHEMIE LTD - CENTRAL FACTORY - CYPRUSMEDOCHEMIE LTD - FACTORY AZ (PRIMARY & SECONDARY PACKAGER) (CYPRUS)
Type
Therapeutic
Approval Details
Approval Id
5605fc951277f8fc
Drug Name
DAPRIL 5 TABLET 5 MG
Product Name
DAPRIL 5 TABLET 5 MG
Approval Number
SIN11994P
Approval Date
2002-06-24
Registrant
MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder
MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09AA03
Atc Item Name
lisinopril
Pharma Manufacturer Name
MEDOCHEMIE SINGAPORE PTE. LTD.
Active Ingredients
LISINOPRIL DIHYDRATE EQV LISINOPRIL
5 mg
LISINOPRIL DIHYDRATE EQV LISINOPRIL
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 24, 2002
Approval ID
5605fc951277f8fc
Type
Therapeutic
Back to HSA Approvals